-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UR8U5UsJUOLByhHj6pnnaGIhREHDcTzXzFu3ra+Y+L5vLKnZcVH7fh/nqgswB3bm jxcdyQ+uIwar030/NkXspA== 0001193125-10-030299.txt : 20100212 0001193125-10-030299.hdr.sgml : 20100212 20100212140313 ACCESSION NUMBER: 0001193125-10-030299 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091231 FILED AS OF DATE: 20100212 DATE AS OF CHANGE: 20100212 EFFECTIVENESS DATE: 20100212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Invus Public Equities Advisors, LLC CENTRAL INDEX KEY: 0001340096 IRS NUMBER: 980420201 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-11522 FILM NUMBER: 10597520 BUSINESS ADDRESS: STREET 1: 135 EAST 57TH STREET, 30TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-317-7520 MAIL ADDRESS: STREET 1: 135 EAST 57TH STREET, 30TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 13F-HR 1 d13fhr.txt FORM 13F SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2009 Check here if Amendment [_]; Amendment Number: ------ This Amendment (Check only one.): [_] is a restatement. [_] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Invus Public Equities Advisors, L.L.C. Address: 750 Lexington Avenue 30th Floor New York, New York 10022 Form 13F File Number: 28-11522 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Khalil Barrage Title: Vice President, Secretary and Treasurer Phone: (212) 317-7520 Signature, Place, and Date of Signing: /s/ Khalil Barrage New York, New York February 12, 2010 - -------------------------------- -------------------- ---------------------- [Signature] [City, State] [Date] Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [_] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 Form 13F Information Table Entry Total: 39 Form 13F Information Table Value Total: $367,890 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. [If there are no entries in this list, state "NONE" and omit the column headings and list entries.] NONE FORM 13F INFORMATION TABLE PERIOD ENDING DECEMBER 31, 2009
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 - ---------------------------- ---------------- ----------- --------- ------------------ TITLE OR VALUE SHRS OR SH/ PUT/ NAME OF ISSUER CLASS CUSIP (x$1,000) PRN AMT PRN CALL - ---------------------------- ---------------- ----------- --------- --------- --- ---- ACORDA THERAPEUTICS INC COM 00484M 10 6 37,800 1,500,000 SH ACORDA THERAPEUTICS INC CALL 00484M 90 6 105 2,000 CALL AK STL HLDG CORP COM 001547 10 8 4,270 200,000 SH ALEXION PHARMACEUTICALS INC COM 015351 10 9 41,497 850,000 SH ANTIGENICS INC DEL COM 037032 10 9 640 1,000,000 SH ANTIGENICS INC DEL NOTE 5.250% 2/0 037032 AC 3 802 2,290,000 SH AUXILIUM PHARMACEUTICALS INC COM 05334D 10 7 35,976 1,200,000 SH BANK OF AMERICA CORPORATION UNIT 99/99/9999 060505 41 9 13,428 900,000 SH BIOVAIL CORP COM 09067J 10 9 4,188 300,000 SH CAPITALSOURCE INC COM 14055X 10 2 3,970 1,000,000 SH CITIGROUP INC COM 172967 10 1 7,448 2,250,000 SH CROWN CASTLE INTL CORP COM 228227 10 4 9,760 250,000 SH EXPRESS SCRIPTS INC COM 302182 10 0 17,284 200,000 SH GOLDMAN SACHS GROUP INC COM 38141G 10 4 15,196 90,000 SH GOOGLE INC CL A 38259P 50 8 12,400 20,000 SH INTEROIL CORP COM 460951 10 6 1,920 25,000 SH JARDEN CORP COM 471109 10 8 6,182 200,000 SH LAMAR ADVERTISING CO CL A 512815 10 1 7,773 250,000 SH LAZARD LTD SHS A G54050 10 2 3,797 100,000 SH LEXICON PHARMACEUTICALS INC COM 528872 10 4 6,615 3,891,108 SH MARTIN MARIETTA MATLS INC COM 573284 10 6 13,903 155,500 SH MASTERCARD INC CL A 57636Q 10 4 10,239 40,000 SH METLIFE INC COM 59156R 10 8 7,070 200,000 SH METLIFE INC CALL 59156R 90 8 35 1,000 CALL MICROVISION INC DEL *W EXP 07/23/201 594960 16 3 505 360,515 SH NEKTAR THERAPEUTICS COM 640268 10 8 12,815 1,375,000 SH ONYX PHARMACEUTICALS INC COM 683399 10 9 8,802 300,000 SH ONYX PHARMACEUTICALS INC CALL 683399 90 9 29 1,000 CALL PEPSICO INC COM 713448 10 8 18,240 300,000 SH QUALCOMM INC COM 747525 10 3 18,504 400,000 SH RESEARCH IN MOTION LTD COM 760975 10 2 5,741 85,000 SH SKECHERS U S A INC 79377W 10 8 9,558 325,000 SH SPDR SERIES TRUST S&P RETAIL ETF 78464A 71 4 1,043 10,000 SH TRANSITION THERAPEUTICS INC COM NEW 893716 20 9 3,600 1,000,000 SH U S AIRWAYS GROUP INC COM 90341W 10 8 2,420 500,000 SH US AIRWAYS GROUP INC NOTE 7.250% 5/1 911905 AC 1 2,580 2,000,000 VISA INC COM CL A 92826C 83 9 10,933 125,000 SH VULCAN MATLS CO CALL 929160 90 9 26 500 CALL WELLS FARGO & CO NEW COM 949746 10 1 10,796 400,000 SH
-----END PRIVACY-ENHANCED MESSAGE-----